Log in

LIBRAINFU Libra Infusions Ltd. DSEBD · Bangladesh

Libra Infusions (LIBRAINFU) news

Libra Infusions Ltd. is a public biotech or pharmaceutical company listed on DSEBD under the ticker LIBRAINFU, recorded under Bangladesh. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Libra Infusions news

We have not published a story on Libra Infusions yet. When there is news, it will appear here.

Questions about Libra Infusions

What is the ticker symbol of Libra Infusions?

Libra Infusions Ltd. trades under the ticker LIBRAINFU on DSEBD.

Where is Libra Infusions listed?

Libra Infusions Ltd. is listed on DSEBD.

Which country or territory is Libra Infusions listed under?

Our directory records Libra Infusions Ltd. under Bangladesh.

What does Libra Infusions do?

Our directory classifies Libra Infusions Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Libra Infusions?

The ISIN recorded for Libra Infusions Ltd. is BD0471LBINF8.

Does aibio.space cover Libra Infusions?

aibio.space lists Libra Infusions Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Libra Infusions?

Companies in our directory listed in the same country and business area as Libra Infusions: Navana Pharmaceuticals, Advanced Chemical Industries, Ambee Pharmaceuticals, Orion Pharma, BN SINA Pharmaceutical Industry, Beximco Pharmaceuticals Plc.

Investor discussion: Libra Infusions

Members talk about Libra Infusions (LIBRAINFU). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Listing details

Libra Infusions Ltd. is a public biotech or pharmaceutical company listed on DSEBD under the ticker LIBRAINFU, recorded under Bangladesh. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Libra Infusions Ltd.
Ticker
LIBRAINFU
Listing
DSEBD
Country or territory
Bangladesh
Business scope
Pharmaceuticals: Major
ISIN
BD0471LBINF8
Last quote in directory
2026-10-19
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.